Dow Up0.08% Nasdaq Down0.30%

Catalyst Pharmaceutical Partners Inc. (CPRX)

-NasdaqCM
3.09 Down 0.03(0.96%) Sep 19, 4:00PM EDT
|After Hours : 3.05 Down 0.04 (1.29%) Sep 19, 7:22PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development2,099  2,749  2,068  2,804  
Selling General and Administrative891  760  639  441  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,990) (3,508) (2,707) (3,246)
Income from Continuing Operations
Total Other Income/Expenses Net(208)(303)1,352  (2,666)
Earnings Before Interest And Taxes(3,198)(3,811)(1,355)(5,912)
Interest Expense -   -   -   -  
Income Before Tax(3,198)(3,811)(1,355)(5,912)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,198)(3,811)(1,355)(5,912)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,198) (3,811) (1,355) (5,912)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,198) (3,811) (1,355) (5,912)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.